DK0965040T3 - Fremgangsmåder og midler i relation til retrotransposon og retroviral integration - Google Patents

Fremgangsmåder og midler i relation til retrotransposon og retroviral integration

Info

Publication number
DK0965040T3
DK0965040T3 DK98900593T DK98900593T DK0965040T3 DK 0965040 T3 DK0965040 T3 DK 0965040T3 DK 98900593 T DK98900593 T DK 98900593T DK 98900593 T DK98900593 T DK 98900593T DK 0965040 T3 DK0965040 T3 DK 0965040T3
Authority
DK
Denmark
Prior art keywords
agents
retrotransposon
relation
methods
retroviral integration
Prior art date
Application number
DK98900593T
Other languages
English (en)
Inventor
Stephen Philip Jackson
Jessica Anne Downs
Original Assignee
Kudos Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kudos Pharm Ltd filed Critical Kudos Pharm Ltd
Application granted granted Critical
Publication of DK0965040T3 publication Critical patent/DK0965040T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/9015Ligases (6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Gyroscopes (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
DK98900593T 1997-01-13 1998-01-13 Fremgangsmåder og midler i relation til retrotransposon og retroviral integration DK0965040T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9700574.8A GB9700574D0 (en) 1997-01-13 1997-01-13 Methods and means relating to retrotransposon and retroviral integration
PCT/GB1998/000099 WO1998030903A1 (en) 1997-01-13 1998-01-13 Methods and means relating to retrotransposon and retroviral integration

Publications (1)

Publication Number Publication Date
DK0965040T3 true DK0965040T3 (da) 2003-07-21

Family

ID=10805892

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98900593T DK0965040T3 (da) 1997-01-13 1998-01-13 Fremgangsmåder og midler i relation til retrotransposon og retroviral integration

Country Status (12)

Country Link
US (1) US6242175B1 (da)
EP (1) EP0965040B1 (da)
JP (1) JP2001508175A (da)
AT (1) ATE237135T1 (da)
AU (1) AU729066B2 (da)
CA (1) CA2277483A1 (da)
DE (1) DE69813193T2 (da)
DK (1) DK0965040T3 (da)
ES (1) ES2197454T3 (da)
GB (2) GB9700574D0 (da)
PT (1) PT965040E (da)
WO (1) WO1998030903A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9907687D0 (en) * 1999-04-01 1999-05-26 Kudos Pharm Ltd Assays methods and means
US6569681B1 (en) 2000-03-14 2003-05-27 Transkaryotic Therapies, Inc. Methods of improving homologous recombination
CA2414017A1 (en) * 2000-05-30 2001-12-06 Kudos Pharmaceuticals Limited Inhibiting retrotransposon and retroviral integration by targeting the atm pathway
US7358040B2 (en) * 2001-08-01 2008-04-15 Rigel Pharmaceuticals, Incorporated MRE 11: modulation of cellular proliferation
US7106469B2 (en) * 2001-08-08 2006-09-12 Hewlett-Packard Development Company, L.P. Variable data printing with web based imaging
EP1436406A4 (en) * 2001-09-24 2004-10-13 Blood Ct Res Foundation METHOD FOR MODULATING OR EXAMINING THE KU70 MIRROR IN CELLS
WO2003089573A2 (en) * 2002-04-05 2003-10-30 Fishel Richard A Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
US20060099583A1 (en) * 2002-05-07 2006-05-11 Devine Scott E Compositions and methods for identifying antiviral agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2132452C (en) * 1993-01-21 2003-10-21 The Salk Institute For Biological Studies Casein kinase i-like protein kinase
AU7972594A (en) * 1993-10-12 1995-05-04 Baylor College Of Medicine Hepatitis b virus interacts with cellular dna repair processes

Also Published As

Publication number Publication date
GB2321702A (en) 1998-08-05
ES2197454T3 (es) 2004-01-01
AU5568498A (en) 1998-08-03
WO1998030903A1 (en) 1998-07-16
JP2001508175A (ja) 2001-06-19
GB2321702B (en) 1998-12-23
AU729066B2 (en) 2001-01-25
EP0965040A1 (en) 1999-12-22
DE69813193D1 (de) 2003-05-15
GB9700574D0 (en) 1997-03-05
US6242175B1 (en) 2001-06-05
DE69813193T2 (de) 2004-03-04
GB9800660D0 (en) 1998-03-11
EP0965040B1 (en) 2003-04-09
PT965040E (pt) 2003-08-29
CA2277483A1 (en) 1998-07-16
ATE237135T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
Stewart et al. Novel species of tRNA
DE69802191D1 (de) Festphase nukleinsäure-isolierung
DK1032705T3 (da) Probearrays og fremgangsmåder til at benytte probearrays til at skelne mellem DNA
ATE244759T1 (de) Stabilisierte zusammensetzungen von reverser transkriptase und rna polymerase für nukleinsäureamplifikation
ATE507300T1 (de) Rekombinante konstrukte und ihre verwendung bei der reduzierung der genexpression
DE69940265D1 (de) Alzheimersche krankheit sekretase
BR9507678A (pt) Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura
DK1266018T3 (da) Fremstilling af udskilte proteiner af rekombinante, eukaryotiske celler
DE69738905D1 (de) Methoden und zusammensetzungen zur transformation von zellen
DE69030449D1 (de) Verfahren und kit zur reinigung von nukleinsäure
WO1999006557A3 (en) Mammalian cell membrane proteins; related reagents
ATE361668T1 (de) Kombinierte tumor suppressor-gen-therapie und chemotherapie bei der neoplasmabehandlung
DK0965040T3 (da) Fremgangsmåder og midler i relation til retrotransposon og retroviral integration
ES2134924T3 (es) Acidos sulfonilalcanoilamino-hidroxietilamino-sulfamicos utiles como inhibidores de proteasas retrovirales.
PT942999E (pt) Construcao armadilha de genes para a identificacao e isolamento de genes
NO20000576D0 (no) Blanding og fremgangsmåte for regulering av celleproliferasjon og celledoed
ATE292689T1 (de) Verbesserte verfahren zur transfektion der t- zellen
Ranu Regulation of protein synthesis in rabbit reticulocyte lysates: The heme-regulated protein kinase (Hri) and double stranded rna induced protein kinase (Dri) phosphorylate the same Site (S) on initiation factor eif-2
DK264890D0 (da) Fremgangsmaade til biokemisk oxidation af steroider og genetisk konstruerede celler til denne anvendelse
SE9703663D0 (sv) Beta recombinase
CO4790179A1 (es) Procedimiento para la fabricacion de proteinas humanas por activacion genica endogena
ATE302282T1 (de) Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen
DK0973918T3 (da) Gærceller, der omfatter mindst to kopier af et önsket gen integreret i det kromosomale genom ved mere end et ikke-ribosomalt RNA-kodende domæne, navnlig med Kluyveromyces
AUPQ923400A0 (en) Assays for alternative lengthening of telomeres
ATE214428T1 (de) Von enzymen katalysierte chemilumineszente detektion von proteinen und nukleinsäuren durch verwendung von hydroxyaryl-cyclischen diacylhydrazid-zusammensetzungen